Verve Therapeutics jumps on report Eli Lilly eyeing co in up to $1.3 billion deal
17/06/2025 09:31
** Genetic medicines co Verve Therapeutics' VERV.O shares jump 82.6% to $11.45 in choppy premarket trading ** Eli Lilly LLY.N is in talks to buy VERV for up to $1.3 billion to expand its experimental drug pipeline, Financial Times reports ** The deal could be announced as early as this week, provided talks stay on track - FT, citing people familiar with the matter ** VERV up ~11% so far this year through Monday (Reporting by Joel Jose in Bengaluru) ((joeljose@thomsonreuters.com;))